been shown formally to associate with either carbohydrate, but we demonstrate that ␤-GBD belongs to this family and show that it binds glycogen. Thus, ␤-GBD represents a new subfamily of glycogen binding Summary modules.
The ␤-GBD sequence is highly conserved across the AMP-activated protein kinase (AMPK) is a multisubstrate enzyme activated by increases in AMP during AMPK/SNF1 ␤ subfamily ( Figure 3A ). We constructed a 3D homology model of ␤-GBD ( Figure 3B) Figure 3C ) that is strikingly similar to bindforms of each subunit comprising ␣1, ␣2, ␤1, ␤2, ␥1, ␥2, and ␥3, which have varying tissue and subcellular ing site 1 in the glucoamylase and cyclodextrin glycosyltransferase starch binding domains [13, 14] . When malexpression [5, 6] . Mutations in the AMPK ␥ subunit cause glycogen storage disease in humans [7] , but totriose was modeled into the glycogen binding site, the apolar faces of two sugars stacked against the aromatic the molecular relationship between glycogen and the AMPK/Snf1p kinase subfamily has not been apparent.
rings of W100 and W133 ( Figure 3C ). The dual specificity phosphatase laforin ( Figure 1B ) contains a glycogen We show that the AMPK ␤ subunit contains a functional glycogen binding domain (␤-GBD) that is most binding domain belonging to the more distally related CBM family 20 and shares the equivalent residues of closely related to isoamylase domains found in glycogen and starch branching enzymes. Mutation of key W100, K126, and W133. Mutation of these residues also prevents laforin binding to glycogen [15] . glycogen binding residues, predicted by molecular modeling, completely abolished ␤-GBD binding to glyWe show that mutation of putative key binding residues of ␤-GBD, W100G and K126Q, completely abolcogen. AMPK binds to glycogen but retains full activity. Overexpressed AMPK ␤1 localized to specific ished ␤-GBD binding to glycogen, whereas the W133L mutation only partially inhibited binding ( Figure 3D ). Mumammalian subcellular structures that corresponded with the expression pattern of glycogen phosphorytation of the AMPK ␤ autophosphorylation site S108 contained within the ␤-GBD [16] to glutamic acid parlase. Glycogen binding provides an architectural link tially inhibited glycogen binding ( Figure 3D ), whereas between AMPK and a major cellular energy store and alanine had no effect. In yeast, the ␤ homolog, Gal83p, juxtaposes AMPK to glycogen bound phosphatases.
contains a mutation (G235R) within its glycogen binding domain [17] that causes the Snf1p substrate Sip4p (a Results and Discussion transcriptional activator) to become insensitive to glucose suppression [18] . We find that the equivalent A putative domain of the AMPK ␤ subunit contained G147R mutation in ␤-GBD partially inhibited glycogen within residues 42-183 was identified by using sequence binding ( Figure 3D ). Arg at position 147 would be exsearches and secondary structure predictions ( We used purified rat liver AMPK to confirm that the 
glycogen. Since several studies have reported that activation of AMPK is reduced in tissues containing high levels of glycogen [19, 20], we tested the effect of glycotains a glycogen binding domain that targets AMPK to glycogen (Figure 5). Several lines of evidence now link gen and found that it did not affect the activity of AMPK directly (Figure 4). To study the subcellular localization
AMPK to glycogen metabolism. The yeast homolog Snf1p is important for maintaining glycogen levels [22] . of the AMPK ␤1 subunit, we transiently expressed ␤1-GFP in COS-7 cells together with glycogen phosphoryGlycogen synthase, an AMPK substrate [19] , and glycogen phosphorylase coimmunoprecipitate with AMPK lase (GP) tagged to Discosoma sp. red fluorescent protein. AMPK ␤1-GFP colabeled glycogen bodies with GP, [6] . Mutation in AMPK ␥3 (R200Q) causes glycogen accumulation and reduced meat quality in Hampshire pigs as shown in Figure 5 , and thereby demonstrated that AMPK localizes to glycogen in vivo. The glycogen bodies [23] . By contrast, reduced muscle glycogen and improved meat yields are linked to the adjacent V199I ␥3 were similar in size and shape to those reported when the dual-specificity phosphatase laforin was overexvariant [24] . In humans, six mutations in AMPK ␥2 have been found in individuals exhibiting cardiac hypertrophy pressed [15] and to those reported in the companion paper [21] , which reports that AMPK ␤1/␤2 colocalized due to glycogen accumulation in cardiomyocytes and ventricular preexcitation typical of the Wolff-Parkinsonwith glycogen synthase.
In summary, we show that the AMPK ␤ subunit conWhite (WPW) syndrome [7] . Thus, just as the AMPK Glycogen is shown as a branched structure. PP1, protein phosphatase 1; PTG, protein targeting to glycogen [26] .
